ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AKLI Akili Inc

0.4307
-0.002 (-0.46%)
After Hours
Last Updated: 23:07:21
Delayed by 15 minutes
Share Name Share Symbol Market Type
Akili Inc NASDAQ:AKLI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.002 -0.46% 0.4307 0.4307 0.44 0.44 0.421001 0.4327 104,629 23:07:21

Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET

19/10/2022 12:00pm

Business Wire


Akili (NASDAQ:AKLI)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Akili Charts.

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its third quarter financial results on Thursday, November 10, 2022 at 4:30 p.m. ET.

A live audio webcast of the conference call and presentation will be available at www.akiliinteractive.com under Investor Relations, Events & Presentations. An archived version of the webcast will be available on the company’s website following the event.

To access the call, dial 877-405-1224 (toll-free) or 201-389-0848 (international) and reference “Akili Q3 2022 Earnings”. International toll-free numbers are available here.

About Akili

Akili is pioneering the development of cognitive treatments through game-changing technologies. Our approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com.

Investor: Joshua Young VP of Investor Relations jyoung@akiliinteractive.com Media: Julie DiCarlo SVP, Communications julie@akiliinteractive.com

1 Year Akili Chart

1 Year Akili Chart

1 Month Akili Chart

1 Month Akili Chart

Your Recent History

Delayed Upgrade Clock